Envestnet Portfolio Solutions Inc. lowered its stake in Relx Plc (NYSE:RELX – Free Report) by 1.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 46,175 shares of the technology company’s stock after selling 489 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Relx were worth $2,097,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. FMR LLC boosted its position in Relx by 8.3% in the third quarter. FMR LLC now owns 7,148,837 shares of the technology company’s stock valued at $339,284,000 after buying an additional 548,423 shares in the last quarter. Natixis Advisors LLC lifted its holdings in shares of Relx by 2.8% during the fourth quarter. Natixis Advisors LLC now owns 1,202,592 shares of the technology company’s stock worth $54,622,000 after purchasing an additional 32,739 shares during the period. Captrust Financial Advisors lifted its holdings in shares of Relx by 3.4% during the third quarter. Captrust Financial Advisors now owns 1,103,797 shares of the technology company’s stock worth $52,386,000 after purchasing an additional 35,807 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Relx during the fourth quarter worth $44,516,000. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Relx by 14.6% during the third quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company’s stock worth $39,225,000 after purchasing an additional 104,999 shares during the period. Institutional investors and hedge funds own 15.02% of the company’s stock.
Relx Stock Performance
Shares of RELX opened at $49.94 on Friday. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The stock has a market capitalization of $92.70 billion, a P/E ratio of 26.85, a price-to-earnings-growth ratio of 2.73 and a beta of 0.90. The firm’s fifty day simple moving average is $49.11 and its two-hundred day simple moving average is $47.67. Relx Plc has a 12 month low of $40.25 and a 12 month high of $51.99.
Relx Increases Dividend
Analysts Set New Price Targets
A number of brokerages have recently commented on RELX. Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th. StockNews.com lowered shares of Relx from a “buy” rating to a “hold” rating in a report on Tuesday, March 4th. Finally, Redburn Atlantic began coverage on shares of Relx in a report on Wednesday, January 8th. They set a “buy” rating on the stock.
Read Our Latest Stock Report on Relx
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
- Five stocks we like better than Relx
- Roth IRA Calculator: Calculate Your Potential Returns
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- With Risk Tolerance, One Size Does Not Fit All
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- How Investors Can Find the Best Cheap Dividend Stocks
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.